News Center

In recent years, Lifotronic Technology, driven by innovation, has transcended borders, injecting new momentum into the healthcare systems of various countries and regions. We are also exploring new models of medical cooperation with local healthcare and research institutions, allowing the seeds of Chinese life sciences to take root and flourish around the world.

Comprehensive Health, Precise Positioning

During Medic East Africa, Lifotronic Technology presents a series of products across multiple technology platforms, including ECLIA, HPLC, CBC and POCT, attracting numerous professionals from the healthcare field to engage with our team.
 

To meet the testing needs of laboratories at all levels, Lifotronic Technology has launched a series of hemoglobin analyzers that cover high, medium, and low customer segments, providing comprehensive and precise diagnostic support for diabetes patients worldwide. The GH-900Plus and H8 are featured at this exhibition. The GH-900Plus can report HbA1c and variants within 180 seconds, making it an ideal choice for small to medium-sized laboratories and grassroots hospitals. The H8 is suitable for HbA1c or thalassemia testing with small sample volumes.

The ECLIA analyzer eCL8000, known as the "King of Emergency," offers a compact design, rapid testing of cardiac and inflammation markers in just 9 minutes, and an intelligent operating system, providing precise technical support for international small and medium-sized laboratories and emergency departments.

Lifotronic Technology is also making strides in the field of hematology analyzers, offering 3-diff and 5-diff CBC testing solutions. The AC310 3-part hematology analyzer, suitable for laboratories with smaller daily sample volumes, was showcased as a fundamental testing tool.

In the POCT field, Lifotronic Technology focuses on the application of fluorescent immunochromatography and colloidal gold rapid detection technologies across multiple scenarios, providing comprehensive solutions. The FA-160 analyzer, with its extensive test parameters, compact portable design, and rapid accurate results, also drew significant attention at the exhibition. It is tailored for international small and medium-sized laboratories, covering tests for inflammation, cardiovascular diseases, diabetes, and other diverse medical testing needs.

United for a Common Cause

By 2030, the population of East Africa is expected to reach 237 million, with more than half being children and adolescents. Governments in the region are actively increasing financial support for healthcare. Currently, Kenya’s healthcare investment accounts for 5% of GDP. According to government data, per capita healthcare spending has risen from $17 to $40, a growth rate of 235%. The Kenyan government has established a twenty-year plan (2010-2030) to develop its healthcare services. Medic East Africa, as a major medical exhibition in the region, will introduce advanced medical technologies and services to drive rapid development in local healthcare.
 

As a global provider of professional medical products and services, Lifotronic Technology will support hospital collaborations between China and Africa, assist in the establishment of key specialty centers, and work together to enhance medical development and healthcare service levels in Africa. We aim to improve public health systems and actively promote the construction of a health community between China and Africa. We believe that in the future, there will be many new stories to tell in the "Health Pact" between China and Africa.